Polymerase Chain Reaction Detection ofChlamydia pneumoniaein Circulating White Blood Cells
The Journal of Infectious Diseases2000Vol. 181(s3), pp. S452–S454
Citations Over TimeTop 10% of 2000 papers
Abstract
Several recently published studies suggest that Chlamydia pneumoniae may represent a risk factor for atherosclerosis or its complications. In order to establish whether C. pneumoniae is causally linked to atherosclerotic diseases, clinical intervention trials may be needed. However, to identify eligible subjects with a persistent C. pneumoniae infection and to monitor the effect of antibiotic therapy, there is a need for a reliable diagnostic marker. Blood-based polymerase chain reaction assays may be of value for identifying patients persistently infected with C. pneumoniae and for assessing the microbiologic efficacy of antichlamydial therapy in clinical intervention trials.
Related Papers
- → Are ELISA and PCR Discrepancies in the Identification of Chlamydia pneumoniae Caused by the Presence of “Chlamydia-Related Bacteria”?(2023)4 cited
- → Rapid and Standardized Detection of Chlamydia pneumoniae Using LightCycler Real-Time Fluorescence PCR(2003)45 cited
- → Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum(2009)6 cited
- DIRECT AND INDIRECT EVIDENCE OF CHLAMYDIA PNEUMONIAE IN PATIENTS WITH SIGNIFICANT STENOSIS OF A. CAROTIS OF ATHEROSCLEROTIC ORIGIN(2004)
- → Identification ofChlamydia pneumoniae-specific protein antigens in immunoblots(1993)29 cited